Search hospitals
>
North Carolina
>
Chapel Hill
UNC Lineberger Comprehensive Cancer Center
Claim this profile
Chapel Hill, North Carolina 27514
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Leukemia
Conducts research for Lung Cancer
Conducts research for Lymphoma
887 reported clinical trials
71 medical researchers
Summary
UNC Lineberger Comprehensive Cancer Center is a medical facility located in Chapel Hill, North Carolina. This center is recognized for care of Breast Cancer, Cancer, Leukemia, Lung Cancer, Lymphoma and other specialties. UNC Lineberger Comprehensive Cancer Center is involved with conducting 887 clinical trials across 715 conditions. There are 71 research doctors associated with this hospital, such as Emily Greengard, Stuart H. Gold, David E. Kram, and Jared Weiss, MD.
Area of expertise
Breast Cancer
UNC Lineberger Comprehensive Cancer Center has run 127 trials for Breast Cancer. Some of their research focus areas include:
Cancer
UNC Lineberger Comprehensive Cancer Center has run 105 trials for Cancer. Some of their research focus areas include:
Top PIs
Emily Greengard
University of Minnesota/Masonic Cancer Center
6 years of reported clinical research
Stuart H. Gold
UNC Lineberger Comprehensive Cancer Center
8 years of reported clinical research
David E. Kram
Wake Forest University Health Sciences
8 years of reported clinical research
Jared Weiss, MD
Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill
4 years of reported clinical research
Clinical Trials running at UNC Lineberger Comprehensive Cancer Center
Breast Cancer
Bladder Cancer
Skin Cancer
Cancer
Breast cancer
Ovarian Cancer
Bladder Carcinoma
Pancreatic Cancer
Kidney Cancer
Testicular cancer
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting
2 awards
Phase 3
8 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting
2 awards
Phase 3
19 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting
2 awards
Phase 3
47 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UNC Lineberger Comprehensive Cancer Center?
UNC Lineberger Comprehensive Cancer Center is a medical facility located in Chapel Hill, North Carolina. This center is recognized for care of Breast Cancer, Cancer, Leukemia, Lung Cancer, Lymphoma and other specialties. UNC Lineberger Comprehensive Cancer Center is involved with conducting 887 clinical trials across 715 conditions. There are 71 research doctors associated with this hospital, such as Emily Greengard, Stuart H. Gold, David E. Kram, and Jared Weiss, MD.
Where is UNC Lineberger Comprehensive Cancer Center located?
The UNC Lineberger Comprehensive Cancer Center, situated on the University of North Carolina campus in Chapel Hill, is the state's sole public comprehensive cancer center. It operates within the N.C. Cancer Hospital. The center's address is 101 Manning Drive, Chapel Hill, NC 27514.
Who should I call to ask about financial aid or insurance network?
For financial assistance at UNC Lineberger Comprehensive Cancer Center: - Contact the Financial Assistance Program at UNC Health as detailed in their brochure. - For insurance-related matters, reach out to Cindy Rogers, JD, director of patient assistance with the Comprehensive Cancer Support Program. - For health insurance information, call (855) 408-1212. - For Medicaid assistance, contact your county Department of Social Services or the Medicaid Counselors at UNC Hospitals at (984) 974-0950.
What insurance does UNC Lineberger Comprehensive Cancer Center accept?
The UNC Lineberger Comprehensive Cancer Center accepts Medicare, Medicaid, and various private insurance plans, including those through the Affordable Care Act Marketplace, UNC Health Care, and UNC Physicians Network. To apply for Medicaid, contact your county Department of Social Services or the Medicaid Counselors at UNC Hospitals. Ensure your specific doctors and services are covered by your insurance plan.
What awards or recognition has UNC Lineberger Comprehensive Cancer Center received?
The UNC Lineberger Comprehensive Cancer Center, located in Chapel Hill, North Carolina, has been recognized as one of nine national research sites for the National Cancer Institute's Cancer Screening Research Network (CSRN). This center is renowned for its dedication to providing quality cancer care and is distinguished by its Cancer Outcomes Research Program.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.